Larvol Delta - OBI-Pharma-Announces-First-Patient-Enrolled-on-SWOG-Cancer-Research-Network39s-OBI3424-Phase-12-Study-Targeting-AKR1C3-in-TALL-and-TLBL

OBI-3424 - OBI Pharma

https://www.prnewswire.com/news-releases/obi-pharma-announces-first-patient-enrolled-on-swog-cancer-research-networks-obi-3424-phase-12-study-targeting-akr1c3-in-t-all-and-t-lbl-301275694.html

Apr 26, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next